We assume that the combination of both PTEN and p16 as prognostic factors may enhance the prognostic validity; however, as our cohort was limited to a small number of PTEN−/p16− cases, results should be re-evaluated in larger or previously published chordoma cohorts. The gene discussed is PTEN; the disease is chordoma.